Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Genex Bone Graft Substitute

K-Number: K212721 · 2022-02-04

Decision Date2022-02-04
Product CodeMQV
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Genex Bone Graft Substitute is a medical device manufactured by Biocomposites, Ltd.. It received FDA 510(k) clearance on 2022-02-04 under approval number K212721. The device is classified under product code MQV. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Genex Bone Graft Substitute?

Genex Bone Graft Substitute is a medical device that received FDA 510(k) clearance on 2022-02-04. It is manufactured by Biocomposites, Ltd.. The 510(k) number is K212721.

When was Genex Bone Graft Substitute approved by the FDA?

Genex Bone Graft Substitute received FDA 510(k) clearance on 2022-02-04, under approval number K212721.

What company makes Genex Bone Graft Substitute?

Genex Bone Graft Substitute is manufactured by Biocomposites, Ltd..

What is the FDA product code for Genex Bone Graft Substitute?

The FDA product code for Genex Bone Graft Substitute is MQV.

Related Clinical Trials

Other Devices by Biocomposites, Ltd.

Related Devices (Code: MQV)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.